GLP-1 Advice with Obesity Medicine Trailblazer Dr. Ken Fujioka

Claim your complimentary gift of my exclusive mini weight care guide today!

Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)

What if the real breakthrough in weight loss isn’t just the medication—but how it’s actually used day to day?

This week’s conversation features Dr. Ken Fujioka, a longtime leader in obesity medicine who has helped shape the field from its early days to where it is now. As Director of Nutrition and Metabolic Research and Obesity Telemedicine at Scripps Clinic, with over 150 clinical trials and 125+ published studies, his perspective brings both depth and real-world clarity to the GLP-1 conversation.

We talk about how medications like semaglutide and tirzepatide have changed obesity care—making meaningful weight loss more achievable while improving overall health. But just as important, we get into the realities behind the trend: the risks of improper use, the rise of unregulated access, and why proper medical guidance still matters.

Here’s what we cover:

• How GLP-1 medications are transforming weight loss and metabolic health
• The risks of getting these medications from untrained or non-medical sources
• Why dosing should be slow, steady, and individualized
• What “non-linear” weight loss actually looks like in real life
• How to pair the medication with nutrition, protein, and smarter food choices
• The role of strength training in protecting muscle and bone
• Why supplements like calcium and fiber may be needed
• How food tracking can be used as a tool for awareness—not restriction

If you want a clearer, more grounded understanding of how GLP-1s are really being used in clinical practice today, the full episode with Dr. Ken Fujioka goes much deeper into all of this.

Connect with me:

• Instagram: doctorfrancavilla
• Facebook: Help Your Patients Lose Weight with Dr. Francavilla
• Website: Dr. Francavilla Show
• Youtube: The Doctor Francavilla Show
• GLP Strong: glpstrong.com